ARCHIVES

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

December 29, 2006

FDA News< Regulations To Ease For Advertising Drugs On TV, Radio

September 12, 1997

ACS Research Budget Over $82 Million

July 17, 1987

In Brief: IU Cancer Center To Receive $15 Million for Breast Cancer

January 31, 2014

In Brief: Voters Support Increase In Research Funds, Poll Finds; Baynes Heads BMT Unit In Detroit

February 28, 1997

In Brief: Wyngaarden To Leave This summer; Fauci Probably Could Have The Job, May No Want It

April 28, 1989